These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuromuscular and cardiac comorbidity determines survival in 140 patients with left ventricular hypertrabeculation/noncompaction. Stöllberger C; Blazek G; Wegner C; Winkler-Dworak M; Finsterer J Int J Cardiol; 2011 Jul; 150(1):71-4. PubMed ID: 20226551 [TBL] [Abstract][Full Text] [Related]
3. Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction. Stöllberger C; Blazek G; Gessner M; Bichler K; Wegner C; Finsterer J Herz; 2015 Sep; 40(6):906-11. PubMed ID: 25939437 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of left ventricular hypertrabeculation/noncompaction is dependent on cardiac and neuromuscular comorbidity. Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J Int J Cardiol; 2007 Oct; 121(2):189-93. PubMed ID: 17188376 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of Neuromuscular Co-morbidity, Left Bundle Branch Block, and Atrial Fibrillation to Predict the Long-Term Prognosis of Left Ventricular Hypertrabeculation/Noncompaction. Stöllberger C; Hasun M; Winkler-Dworak M; Finsterer J Am J Cardiol; 2020 Aug; 128():168-173. PubMed ID: 32650915 [TBL] [Abstract][Full Text] [Related]
6. Association of electrocardiographic abnormalities with cardiac findings and neuromuscular disorders in left ventricular hypertrabeculation/non-compaction. Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J Cardiology; 2007; 107(4):374-9. PubMed ID: 17284898 [TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation in left ventricular noncompaction with and without neuromuscular disorders is associated with a poor prognosis. Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J Int J Cardiol; 2009 Mar; 133(1):41-5. PubMed ID: 18255171 [TBL] [Abstract][Full Text] [Related]
8. Cardiologic and neuromuscular co-morbidity influences mortality of patients with left ventricular hypertrabeculation/noncompaction: comparison with the Austrian general population. Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J Acta Cardiol; 2007 Feb; 62(1):1-5. PubMed ID: 17375885 [TBL] [Abstract][Full Text] [Related]
10. In- and outpatients with noncompaction: differences in cardiac and neuromuscular co-morbidity. Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J Int J Cardiol; 2010 Apr; 140(1):108-11. PubMed ID: 19095319 [TBL] [Abstract][Full Text] [Related]
11. [Sex differences in left ventricular noncompaction in patients with and without neuromuscular disorders]. Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J Rev Esp Cardiol; 2008 Feb; 61(2):130-6. PubMed ID: 18364181 [TBL] [Abstract][Full Text] [Related]
12. Neuromuscular implications in left ventricular hypertrabeculation/noncompaction. Finsterer J; Stöllberger C; Blazek G Int J Cardiol; 2006 Jun; 110(3):288-300. PubMed ID: 16364474 [TBL] [Abstract][Full Text] [Related]
13. Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction. Finsterer J; Stöllberger C; Fazio G Curr Pharm Des; 2010; 16(26):2895-904. PubMed ID: 20632953 [TBL] [Abstract][Full Text] [Related]
14. Evolution of electrocardiographic abnormalities in association with neuromuscular disorders and survival in left ventricular hypertrabeculation/noncompaction. Stöllberger C; Gerger D; Jirak P; Wegner C; Finsterer J Ann Noninvasive Electrocardiol; 2014 Nov; 19(6):567-73. PubMed ID: 24934299 [TBL] [Abstract][Full Text] [Related]
15. Age-dependency of cardiac and neuromuscular findings in adults with left ventricular hypertrabeculation/noncompaction. Stöllberger C; Blazek G; Gessner M; Bichler K; Wegner C; Finsterer J Am J Cardiol; 2015 May; 115(9):1287-92. PubMed ID: 25791238 [TBL] [Abstract][Full Text] [Related]
16. Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication. Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J Int J Cardiol; 2007 Jun; 119(1):28-32. PubMed ID: 17023079 [TBL] [Abstract][Full Text] [Related]
17. Quantitative electrocardiographic measures, neuromuscular disorders, and survival in left ventricular hypertrabeculation/noncompaction. Stöllberger C; Gerger D; Wegner C; Finsterer J Ann Noninvasive Electrocardiol; 2013 May; 18(3):251-5. PubMed ID: 23714083 [TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrabeculation/noncompaction with and without neuromuscular disorders. Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J Int J Cardiol; 2004 Oct; 97(1):89-92. PubMed ID: 15336813 [TBL] [Abstract][Full Text] [Related]
19. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator. Schernthaner C; Pichler M; Strohmer B Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140 [TBL] [Abstract][Full Text] [Related]
20. CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction. Stöllberger C; Wegner C; Finsterer J J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):709-12. PubMed ID: 22142779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]